Table 2 Survey participant characteristics according to whether they received Artemether-lumefantrine (AL) or Dihydroartemisinin-piperaquine (DHA-PPQ)
| Â | Study arm | Â | |
|---|---|---|---|
| Â | AL n(%) | DHA-PPQ n(%) | P a |
Child sex | Â | Â | Â |
Female | 59 (58) | 68 (58) | Â |
Male | 42 (42) | 49 (42) | 0.97 |
Child age | Â | Â | Â |
<24 months | 30 (30) | 26 (22) | Â |
24-35 months | 53 (52) | 76 (65) | Â |
36-47 months | 18 (18) | 15 (13) | 0.17 |
Maternal education | Â | Â | Â |
None | 25 (25) | 35 (30) | Â |
Primary | 45 (45) | 52 (44) | Â |
Secondary + | 31 (31) | 30 (26) | 0.60 |